Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Amazon, Alphabet And A Pharmaceutical Giant: CNBC's 'Final Trades'

Published 08/04/2024, 13:36
Updated 08/04/2024, 14:40
© Reuters.  Amazon, Alphabet And A Pharmaceutical Giant: CNBC's 'Final Trades'

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said Amazon.com, Inc. (NASDAQ: AMZN) is on the cusp of an all-time high.

Amazon.com is restarting construction of a 42-story office tower in Bellevue, a Seattle suburb, after halting work on 22 floors since 2022. The pause in 2022 affected five towers in Bellevue and new offices in Virginia and Nashville as Amazon evaluated the pandemic’s impact on in-office work dynamics.

Stephen Weiss of Short Hills Capital Partners said Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL) has got a long way to go.

Alphabet has once again secured the top position in the list of “America’s Most Innovative Companies 2024,” despite facing internal criticism and AI-related challenges. Last month, Fortune and Statista revealed that Alphabet has maintained its leading position for the second consecutive year. This is despite the company’s internal turmoil and AI-related issues.

Don’t forget to check out our premarket coverage here

Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC said Pfizer Inc. (NYSE: PFE) has a 6.3% dividend yield.

On April 5, Cantor Fitzgerald analyst Louise Chen reiterated Pfizer with an Overweight and maintained a $45 price target.

Price Action:

  • Amazon shares gained 2.8% to close at $185.07 on Friday.
  • Alphabet shares gained 1.3% to settle at $153.94 on Friday.
  • Pfizer shares rose 0.04% to settle at $26.66 during Friday’s session.

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.